Our objective is to accelerate discoveries in fundamental Rett syndrome research toward clinical testing, with the goal of improving the lives and treatments of those diagnosed with Rett syndrome. Our emphasis on translational and clinical research will ensure that new ideas are constantly flowing into the drug pipeline and neuro-habilitation platforms aimed at accelerating treatments for Rett syndrome.
We are building a better understanding of the therapeutic needs for Rett syndrome through the Rett Natural History Study and implementing a translational research agenda based on the key biology that needs to be targeted for treatment. Our efforts are in two areas:
Research exploring specific pharmacologic approaches that could contribute to the development of drugs correcting the biology of Rett syndrome.
Research to develop tools and resources that will help reset the neurological development in Rett syndrome.
Through our annual call for proposals we fund new ideas identifying relevant biological targets and promising therapeutics that can benefit the Rett syndrome community. Our current clinical research and drug trials are the largest efforts worldwide to change the clinical course of Rett syndrome.
Programs to Fulfill Our Research Plan
The Basic Research Program
To correct the biology we first must understand what has gone wrong
The Translational Research Program
To develop treatments that change the biology of Rett Syndrome
- The Scout Program
To develop ideas into medicines
The Neuro-Habilitation Program
To reset the neurology we must find methods to habilitate cognition, speech, occupational and physical activities
The Natural History Study and Clinical Trials Network Program
To build a national clinical trials network through a partnership with the federal government and fully understand the clinical aspects of Retts syndrome while conducting clinical trials aimed to correct Rett biology
The Mentored Training Fellowship Program
To build the lab bench of future Rett syndrome researchers